View Single Post
Old 04-15-2010, 01:16 PM
paula_w paula_w is offline
In Remembrance
 
Join Date: Aug 2006
Location: Florida
Posts: 3,904
15 yr Member
paula_w paula_w is offline
In Remembrance
 
Join Date: Aug 2006
Location: Florida
Posts: 3,904
15 yr Member
Default gdnf...it's back?

http://biotuesday.ca/2010/04/13/in-c...th-erich-mohr/
Conversation with Dr. Eric Mohr

His newest creation, closely held MedGenesis Therapeutix of Victoria, is making waves with a new treatment for serious neurologic diseases called convection-enhanced delivery (CED). Backed with a GDNF (glial cell line-derived neurotrophic factor) protein licensed from Amgen (NASDAQ:AMGN) and collaboration with Biovail (TSX:BVF; NYSE:BVF), MedGenesis and Biovail are tackling Parkinson’s disease. In this exclusive interview with BioTuesday.ca, Dr. Mohr explains the potential of CED and its potential to transform the practice of neurology and the treatment of neurologic diseases.

Last line of article:

"And the next largest shareholder is Andy Grove, the former chairman of Intel."
__________________
paula

"Time is not neutral for those who have pd or for those who will get it."
paula_w is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
imark3000 (04-17-2010), olsen (04-16-2010), Shake 'Em Up (04-19-2010), soccertese (04-15-2010)